Skip to main content
Figure 2 | BMC Medical Genetics

Figure 2

From: Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism

Figure 2

Lipid profile changes in patients receiving NNRTI therapy. No differences were observed between genotypes in regards to serum triglyceride (A) or total cholesterol (B) concentrations. However, carriers of the A allele (closed circles) had significantly decreased HDL-cholesterol values when compared with non-carriers (open circles) at 3, 6, and 12 months after treatment initiation (C). * indicates p < 0.05.

Back to article page